Berkshire reduces Apple stake, FDA to review Moderna vaccine
Morning Brief host Julie Hyman takes a look at some of Wednesday morning's trending tickers and stories. Moderna (MRNA) stock is surging on the US Food and Drug Administration's (FDA's) decision to review the company's flu vaccine, reversing its earlier rejection. New York Times (NYT) stock is on the rise after Berkshire Hathaway (BRK-B, BRK-A) announced a $350 million stake in the news outlet. Berkshire also reduced its stake in Apple (AAPL). Palo Alto Networks (PANW) stock is falling after the company lowered its annual profit forecast. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
